Literature DB >> 8953100

Present studies of therapy for anaerobic infections.

S M Finegold1, H M Wexler.   

Abstract

Therapeutic approaches to anaerobic infections are changing. Debridement, drainage, and other surgical approaches remain extremely important. Resistance to antimicrobial agents currently used for treatment of anaerobic infections is increasing. However, promising new agents are being introduced. We review the current status of therapy for anaerobic infections and discuss the potential role of these new agents. We stress an empirical approach to therapy that is based on the usual infecting flora in various types of infections.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8953100     DOI： 10.1093/clinids/23.supplement_1.s9

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  11 in total

1.  Trends in antimicrobial resistance among clinical isolates of the Bacteroides fragilis group from 1992 to 1997 in Montreal, Canada.

Authors:  A C Labbé; A M Bourgault; J Vincelette; P L Turgeon; F Lamothe
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

Review 2.  A primer on anaerobic bacteria and anaerobic infections for the uninitiated.

Authors:  I Olsen; C O Solberg; S M Finegold
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

3.  Trifluoromethionine, a prodrug designed against methionine gamma-lyase-containing pathogens, has efficacy in vitro and in vivo against Trichomonas vaginalis.

Authors:  G H Coombs; J C Mottram
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

4.  BTS guidelines for the management of pleural infection.

Authors:  C W H Davies; F V Gleeson; R J O Davies
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

Review 5.  Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.

Authors:  Vahab Ali; Tomoyoshi Nozaki
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

6.  Maxillary sinusitis of odontogenic origin.

Authors:  Pushkar Mehra; Daniel Jeong
Journal:  Curr Allergy Asthma Rep       Date:  2009-05       Impact factor: 4.806

7.  Maxillary sinusitis of odontogenic origin.

Authors:  Pushkar Mehra; Daniel Jeong
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

8.  The Bfp60 surface adhesin is an extracellular matrix and plasminogen protein interacting in Bacteroides fragilis.

Authors:  Eliane de Oliveira Ferreira; Felipe Lopes Teixeira; Fabiana Cordeiro; Leandro Araujo Lobo; Edson R Rocha; Jeffrey C Smith; Regina M C P Domingues
Journal:  Int J Med Microbiol       Date:  2013-06-21       Impact factor: 3.473

9.  A study of bacteremia in febrile neutropenic patients at a tertiary-care hospital with special reference to anaerobes.

Authors:  P Mathur; R Chaudhry; L Kumar; A Kapil; B Dhawan
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

10.  The rising tide of bloodstream infections with Actinomyces species: bimicrobial infection with Actinomyces odontolyticus and Escherichia coli in an intravenous drug user.

Authors:  Daniel Weiand; Gavin Barlow
Journal:  Oxf Med Case Reports       Date:  2014-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.